SofWave Medical Ltd. (TLV:SOFW)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
3,530.00
+72.00 (2.08%)
At close: Mar 2, 2026
117.10%
Market Cap 1.27B
Revenue (ttm) 255.13M
Net Income (ttm) 2.26M
Shares Out 36.10M
EPS (ttm) 0.06
PE Ratio 562.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 95,822
Average Volume 45,229
Open 3,408.00
Previous Close 3,458.00
Day's Range 3,153.00 - 3,535.00
52-Week Range 1,300.00 - 3,921.00
Beta 0.87
RSI 52.25
Earnings Date Mar 5, 2026

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. The company was incorporated in 2015 a... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2015
Employees 126
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol SOFW
Full Company Profile

Financial Performance

In 2024, SofWave Medical's revenue was $59.65 million, an increase of 18.56% compared to the previous year's $50.32 million. Losses were -$4.55 million, -45.08% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.